Cita APA

Schurad, B., Koch, C., Schug, B., Morte, A., Vaqué, A., Torre Fornell, R. d. l., & Iniesta, M. (2022). Comparative bioavailability study of a novel multi-day patch formulation of rivastigmine (twice weekly) with Exelon® transdermal patch (daily)- a randomized clinical trial.

Citación estilo Chicago

Schurad, Bjoern, Cornelius Koch, Barbara Schug, Adelaida Morte, Anna Vaqué, Rafael de la Torre Fornell, y Marc Iniesta. Comparative Bioavailability Study of a Novel Multi-day Patch Formulation of Rivastigmine (twice Weekly) With Exelon® Transdermal Patch (daily)- a Randomized Clinical Trial. 2022.

Cita MLA

Schurad, Bjoern, et al. Comparative Bioavailability Study of a Novel Multi-day Patch Formulation of Rivastigmine (twice Weekly) With Exelon® Transdermal Patch (daily)- a Randomized Clinical Trial. 2022.